Showing results (11-20 of 199) with videos related to
Sort By:
Pageof 20
Nature Communications|June 15, 2013
Model-based rational design of an oncolytic virus with improved therapeutic potentialFabrice Le Bœuf, Cory Batenchuk, Markus Vähä-Koskela, et al.Iranian Biomedical Journal|December 7, 2007
Intercellular trafficking of VP22, a herpes simplex virus type 1 tegument proteinTaravat Bamdad, John C BellCell Cycle (Georgetown, Tex.)|January 16, 2007
Novel therapeutic target: the PERKs of inhibiting the integrated stress responseJaime Blais, John C BellJournal of Virology|September 29, 2006
Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon productionNavkiran Gill, Philip M Deacon, Brian Lichty, et al.Cancer Research|May 10, 2014
Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potencyAlexander Muik, Lawton J Stubbert, Roza Z Jahedi, et al.Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Introduction to Oncolytic VirotherapyChristine E Engeland, John C BellOncolytic Virotherapy|August 12, 2016
Cell carriers for oncolytic viruses: current challenges and future directionsDominic G Roy, John C BellJournal of Molecular Medicine (Berlin, Germany)|August 6, 2016
Oncolytic viruses-immunotherapeutics on the riseBrian A Keller, John C BellJournal of Medical Imaging and Radiation Sciences|May 5, 2019
Oncolytic Viruses: A New Weapon to Fight CancerChristopher W Brown, John C BellCytokine & Growth Factor Reviews|March 16, 2010
United virus: the oncolytic tag-team against cancer!Fabrice Le Boeuf, John C BellPageof 20